Display Settings:

Format

Send to:

Choose Destination
    Trends Cardiovasc Med. 2008 Oct;18(7):247-53.

    Endothelial nicotinic acetylcholine receptors and angiogenesis.

    Source

    Division of Cardiovascular Medicine, Stanford University, Stanford, CA 94305, USA. john.cooke@stanford.edu

    Abstract

    Nicotinic acetylcholine receptors (nAChRs) were first described in non-excitable cells just more than a decade ago. The nAChRs on endothelial cells modulate key angiogenic processes, including endothelial cell survival, proliferation, and migration. The receptors may be stimulated by endogenous agonists such as acetylcholine, or exogenous chemicals such as nicotine, to activate physiologic angiogenesis (such as in wound healing) or pathologic angiogenesis (such as retinal neovascularization or tumor angiogenesis). The endothelial nAChRs may represent a target for therapeutic modulation of disorders characterized by insufficient or pathologic angiogenesis.

    PMID:
    19232953
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2673464
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 2
    Figure 1

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk